Filed: 4/17/2026ACC: 0001951757-26-000630
📋 What this filing means
PSP RESEARCH LLC filed this quarterly 13F‑HR report disclosing 79 equity positions with a total reported market value of $141.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
79
Positions
$141.33M
Total AUM (reported)
4.40M
Total Shares
Allocation by class
0-3 MNTH TREASRY$70.46M49.9%
STATE STREET SPD$36.39M25.7%
COM$22.51M15.9%
CLASS A COM$4.87M3.4%
COM NEW$1.83M1.3%
SPONSORED ADR$1.04M0.7%
COM SHS$657.7K0.5%
Portfolio Concentration
Top 3$111.72M79.0%
4–10$4.01M2.8%
11–25$7.43M5.3%
Rest$18.17M12.9%
Top 3 weight
79.0%
Top 10 weight
81.9%
Voting Authority Distribution
Total shares with voting rights: 4.40M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
4.40M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole79
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings79
Rows:
ISHARES TR
SOLEShares700K
TypeSH
Market value$70.46M
49.86%
Sole
0.00
Shared
0.00
None
700K
SPDR SERIES TRUST
SOLEShares284.90K
TypeSH
Market value$36.39M
25.75%
Sole
0.00
Shared
0.00
None
284.90K
SERA PROGNOSTICS INC
SOLEShares2.40M
TypeSH
Market value$4.87M
3.44%
Sole
0.00
Shared
0.00
None
2.40M
DEFINIUM THERAPEUTICS INC
SOLEShares34.80K
TypeSH
Market value$657.7K
0.47%
Sole
0.00
Shared
0.00
None
34.80K
TYRA BIOSCIENCES INC
SOLEShares16K
TypeSH
Market value$612.8K
0.43%
Sole
0.00
Shared
0.00
None
16K
ASCENDIS PHARMA A/S
SOLEShares2.50K
TypeSH
Market value$571.8K
0.40%
Sole
0.00
Shared
0.00
None
2.50K
PHARVARIS N V
SOLEShares20K
TypeSH
Market value$565.0K
0.40%
Sole
0.00
Shared
0.00
None
20K
CYTOKINETICS INC
SOLEShares8.30K
TypeSH
Market value$547.1K
0.39%
Sole
0.00
Shared
0.00
None
8.30K
ROYALTY PHARMA PLC
SOLEShares11K
TypeSH
Market value$527.7K
0.37%
Sole
0.00
Shared
0.00
None
11K
KYMERA THERAPEUTICS INC
SOLEShares6.30K
TypeSH
Market value$524.7K
0.37%
Sole
0.00
Shared
0.00
None
6.30K
HALOZYME THERAPEUTICS INC
SOLEShares8.03K
TypeSH
Market value$518.7K
0.37%
Sole
0.00
Shared
0.00
None
8.03K
EXELIXIS INC
SOLEShares11.95K
TypeSH
Market value$512.5K
0.36%
Sole
0.00
Shared
0.00
None
11.95K
DISC MEDICINE INC
SOLEShares8K
TypeSH
Market value$511.5K
0.36%
Sole
0.00
Shared
0.00
None
8K
IONIS PHARMACEUTICALS INC
SOLEShares6.80K
TypeSH
Market value$510.6K
0.36%
Sole
0.00
Shared
0.00
None
6.80K
AGIOS PHARMACEUTICALS INC
SOLEShares15K
TypeSH
Market value$507.4K
0.36%
Sole
0.00
Shared
0.00
None
15K
NEUROCRINE BIOSCIENCES INC
SOLEShares3.85K
TypeSH
Market value$506.9K
0.36%
Sole
0.00
Shared
0.00
None
3.85K
INCYTE CORP
SOLEShares5.30K
TypeSH
Market value$498.8K
0.35%
Sole
0.00
Shared
0.00
None
5.30K
TARSUS PHARMACEUTICALS INC
SOLEShares7K
TypeSH
Market value$491.1K
0.35%
Sole
0.00
Shared
0.00
None
7K
VIKING THERAPEUTICS INC
SOLEShares15K
TypeSH
Market value$488.1K
0.35%
Sole
0.00
Shared
0.00
None
15K
ALNYLAM PHARMACEUTICALS INC
SOLEShares1.47K
TypeSH
Market value$484.7K
0.34%
Sole
0.00
Shared
0.00
None
1.47K
PRAXIS PRECISION MEDICINES I
SOLEShares1.50K
TypeSH
Market value$483.3K
0.34%
Sole
0.00
Shared
0.00
None
1.50K
AXSOME THERAPEUTICS INC.
SOLEShares2.85K
TypeSH
Market value$480.9K
0.34%
Sole
0.00
Shared
0.00
None
2.85K
NEWAMSTERDAM PHARMA COMPANY
SOLEShares15K
TypeSH
Market value$480.1K
0.34%
Sole
0.00
Shared
0.00
None
15K
ARDELYX INC
SOLEShares80K
TypeSH
Market value$479.2K
0.34%
Sole
0.00
Shared
0.00
None
80K
IMMUNOVANT INC
SOLEShares19.20K
TypeSH
Market value$476.9K
0.34%
Sole
0.00
Shared
0.00
None
19.20K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | 0-3 MNTH TREASRY | 700K | SH | $70.46M 49.86% | 0.00 | 0.00 | 700K |
SPDR SERIES TRUSTSOLE | STATE STREET SPD | 284.90K | SH | $36.39M 25.75% | 0.00 | 0.00 | 284.90K |
SERA PROGNOSTICS INCSOLE | CLASS A COM | 2.40M | SH | $4.87M 3.44% | 0.00 | 0.00 | 2.40M |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 34.80K | SH | $657.7K 0.47% | 0.00 | 0.00 | 34.80K |
TYRA BIOSCIENCES INCSOLE | COM | 16K | SH | $612.8K 0.43% | 0.00 | 0.00 | 16K |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 2.50K | SH | $571.8K 0.40% | 0.00 | 0.00 | 2.50K |
PHARVARIS N VSOLE | COM | 20K | SH | $565.0K 0.40% | 0.00 | 0.00 | 20K |
CYTOKINETICS INCSOLE | COM NEW | 8.30K | SH | $547.1K 0.39% | 0.00 | 0.00 | 8.30K |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 11K | SH | $527.7K 0.37% | 0.00 | 0.00 | 11K |
KYMERA THERAPEUTICS INCSOLE | COM | 6.30K | SH | $524.7K 0.37% | 0.00 | 0.00 | 6.30K |
HALOZYME THERAPEUTICS INCSOLE | COM | 8.03K | SH | $518.7K 0.37% | 0.00 | 0.00 | 8.03K |
EXELIXIS INCSOLE | COM | 11.95K | SH | $512.5K 0.36% | 0.00 | 0.00 | 11.95K |
DISC MEDICINE INCSOLE | COM | 8K | SH | $511.5K 0.36% | 0.00 | 0.00 | 8K |
IONIS PHARMACEUTICALS INCSOLE | COM | 6.80K | SH | $510.6K 0.36% | 0.00 | 0.00 | 6.80K |
AGIOS PHARMACEUTICALS INCSOLE | COM | 15K | SH | $507.4K 0.36% | 0.00 | 0.00 | 15K |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 3.85K | SH | $506.9K 0.36% | 0.00 | 0.00 | 3.85K |
INCYTE CORPSOLE | COM | 5.30K | SH | $498.8K 0.35% | 0.00 | 0.00 | 5.30K |
TARSUS PHARMACEUTICALS INCSOLE | COM | 7K | SH | $491.1K 0.35% | 0.00 | 0.00 | 7K |
VIKING THERAPEUTICS INCSOLE | COM | 15K | SH | $488.1K 0.35% | 0.00 | 0.00 | 15K |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 1.47K | SH | $484.7K 0.34% | 0.00 | 0.00 | 1.47K |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 1.50K | SH | $483.3K 0.34% | 0.00 | 0.00 | 1.50K |
AXSOME THERAPEUTICS INC.SOLE | COM | 2.85K | SH | $480.9K 0.34% | 0.00 | 0.00 | 2.85K |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 15K | SH | $480.1K 0.34% | 0.00 | 0.00 | 15K |
ARDELYX INCSOLE | COM | 80K | SH | $479.2K 0.34% | 0.00 | 0.00 | 80K |
IMMUNOVANT INCSOLE | COM | 19.20K | SH | $476.9K 0.34% | 0.00 | 0.00 | 19.20K |
Page 1 of 4